Reg 32

4" November, 2026 The Corporate Relations Department BSE Limited, Rotunga Building, P.J. Towers, Dalal Street, Mumbai - 400001 Scrip Code: 524632 Sub: Disclosure under Regulation 32(1) of SESI (listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to SEBI circular-CIR/CFD/CMD1/162/2019 dated 24™ December, 2019 as amended from time to time till date, regarding Format on Statement of Deviation or Variation for proceeds of public issue/rights issue preferential issue, Qualified Institutions Placement (QIP) etc. in reference to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby confirm that there is no deviation and/or variation in the utilization of proceeds, from the object mentioned in notice of Extra Ordinary general meeting of the members of the company held on 1 Day of November, 2025 for issuance of 46,43,000 (Forty Six Lakhs Forty Three Thousand) Convertible warrants on a preferential basis for cash consideration at a price of Re. 1/- (One Rupees Only) (including the Warrant Subscription Price and the Warrant Exercise Price). The Company has received from the Allottees Seventy-Five Percent of consideration amount aggregating to ¥ 10,46,33,630 (Rupees Ten Crores and Forty-Six Lakhs Thirty-Three Thousand Six Hundred Thirty Only) as required under the SEBI ICDR Regulations. A statement of deviation, stating that there is no deviation or variation in the utilization of these proceeds, duly reviewed by the Audit Committee, is attached herewith as Annexure-A. This is for your information and necessary records. Thanking you, Yours faithfully, For Shukra Medtech Limited (Formerly known as Shukra Pharmaceuticals Limited) Dakshesh Shah Director DIN: 00561666 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhin- a38g27a21r, Gujarat, India, Ph. : 02764-286317 Email: info@shukrapharmaceuticals.com | Website: www.shukrapharamaceuticals.com Statement of Deviation / Variation in utilization of funds raised under Preferential issue - Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements Regulations, 2015 Name of Listed Entity Shukra Medtech Limited (Formerly known as Shukra Pharmaceuticals Limited) Mode of Fund Raising Issuance of Convertible warrants on a preferential basis for cash consideration Date of Raising Fund 2" September, 2026 and 14 July, 2026 Amount Raised 210,46,33,630 (Rupees Ten Crores and Forty-Six Lakhs Thirty-Three Thousand Six Hundred Thirty Only) Report filed for Quarter and Year Ended September 30, 2026 Monitoring Agency NA Monitoring Agency Name, If Applicable NA Is there any Deviation / Variation in use of funds | No raised If yes, Whether the same is pursuant to change in | NA terms of a contract or object, which was approved by the shareholders If Yes, Date of Shareholder approval NA Explanation for Deviation / Variation NA Comments of Audit Committee after review No Comments Comments of auditors if any No Comments CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Anmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email: info@shukrapharmaceuticals.com | Website: www.shukrapharamaceuticals.com Objects for which funds have been raised and where there has been a deviation, in the following table: (Amount in lakhs) Original Object Modified | Original Modified | Funds Amount | Remarks Object, | Allocation allocation, | Utilized of if any if any if any Deviation/ Variation for the quarter according applicable object To meet Working Capital | Nil 575.57 | Nil 575.57 Nil No requirement of the deviation company and to provide margin for Bank Guarantee To Invest in the capital Nil 422.77 | Nil 422.77 Nil No expenditure of the deviation Subsidiary Companies General Corporate | Nil 45.00 | Nil 45.00 Nil No Purposes deviation Deviation or variation could mean: (a) Deviation in the objects or purposefosr which the funds have been raised; or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed; or (c) Change in terms ofa contract referred to in the fund-raising document For Shukra Medtech Limited (Formerly known as Shukra Pharmaceuticals Limited) Dakshesh Shah Director DIN: 00561666 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Anmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhin- a38g27a21r, Gujarat, India, Ph. : 02764-286317 Email: info@shukrapharmaceuticals.com | Website: www.shukrapharamaceuticals.com